Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$548.35 - $738.84 $336,138 - $452,908
613 New
613 $362,000
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $322,030 - $382,018
-561 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$472.8 - $558.54 $67,137 - $79,312
-142 Reduced 20.2%
561 $313,000
Q1 2021

Apr 30, 2021

BUY
$446.73 - $548.2 $314,051 - $385,384
703 New
703 $333,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.